Urinary profiles of protein markers of tubular dysfunction in cases of nephrolithiasis single kidney

##plugins.themes.bootstrap3.article.sidebar##

PDF (Українська)
Published: Nov 30, 2015
DOI: https://doi.org/10.30841/2307-5090.4(55).2015.104765
Keywords:
urolithiasis, one kidney, microalbuminuria, β2 microglobulin,

##plugins.themes.bootstrap3.article.main##

О. Л. Мороз
Национальная медицинская академия последипломного образования имени П.Л. Шупика, Ukraine

Abstract

The study involved 89 people with only single kidney (SK), which is divided into 3 clinical groups: I (n=30) – patients with verified ureter al stones SK and signs of acute calculous obstruction (ACO), which was held transureteral contact lithotripsy; II (n=29) –persons with microlites pelvis and cups SK who did not receive treatment during the study; III (n=30) group – the cases of «healthy» congenital SK, without treatment. Control (IV group) were healthy volunteers (n=10). It was found that the state of the ACO for the SK is characterized by severely impaired glomerular and tubular system, with the need to rehabilitate a certain period after the restoration of urodynamics. Urinary microalbumin profiles and β2 microglobulin in the European Parliament is a violation of 100%, more significantly in complicated forms of urolithiasis and less vyrazitelno – in congenital single kidney. Increased β2 microglobulin in urine at ureterolitiaze only kidney was noted at 29,0%, was characterized by stability during the study and reflects the possibility of its use as a marker of glomerular and tubular dysfunction.

##plugins.themes.bootstrap3.article.details##

How to Cite
Мороз, О. Л. (2015). Urinary profiles of protein markers of tubular dysfunction in cases of nephrolithiasis single kidney. Health of Man, (4(55), 110–113. https://doi.org/10.30841/2307-5090.4(55).2015.104765
Issue
No. 4(55) (2015)
Section
Urology
Copyright (c) 2020 О. Л. Мороз

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biography

О. Л. Мороз, Национальная медицинская академия последипломного образования имени П.Л. Шупика

A.L. Moroz

References

Спиридоненко В.В. Порушення гомеостазу і функціональний стан єдиної нирки, ураженої сечокам’яною хворобою// Урологія. – 2004. – No 2. – С. 12–15.

Спиридоненко В.В. Радіонуклідні дослідження при нефролітіазі єдиної нирки: стан внутрішнього кровотоку // Урологія. – 2004. – No 1. – С. 70–73.

Сміян С.І., Франчук М.Ф. Ефективність Канефрону Н у комплексному лікуванні субклінічної подагричної нефропатії // Здоров’я України. – 2015. – 3 (4). – С. 16–17.

Haffner S.M., Stem M.P., Gruber K.K. et al. 1990. Microalbuminuria. Potential marker for increased cardiovascular risk factors on nondiabetic subjects? //Arteriosclerosis. 10 (5): 727–731.

Bigazzi R., Bianchi S., Baldari D., Campese V.M. 1998. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension // J. Hypertension. 16 (9): 1325–1333.

Cirillo M., Senigalliesi L., Laurenzi M. et al. 1998. Microalbuminuria in nondiabetic adults // Arch. Intern. Med. 158 (17): 1933–1939.

Microalbuminurya [E resourse]. – Acces mode: URL: http://www.indap.info/microalbuminurya.html

The study of renal function [E –resourse]. – Access mode: URL: www.biochemmack.ru/upload/uf/204/2042dda-688fc61b5d5db08ad2350d6dc.pdf.

Братусь В., Талая Т., Шумаков В. Ожирение, инсулинорезистентность, метаболический синдром: основные и клинические аспекты. – К.: Четверта хвиля, 2009. – 413 с.

Schwab S.J., Dunn F.L., Feinglos M.N. 1992. Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis // Diabetes Care.15: 1381–1384.

Clinical practice guidelines for the management odg diabetes in Canada. 1998. // CMAJ. 159 (suppl. 8): S1–S29.

Weiner D. 2008. Uric acid and incident kidney disease in the community. J Am Soc of Nephrol.19.6:1204–1211.

Kanbay M., Solak Y., Dogan E et al. 2010. Uric acid in hypertension and renal disease: The chicken or the egg? // Blood Purif.30:288–295.

Tesla A, Mallamaci F., Spoto B. et al. 2014. Association of a polymorphism in a Gene Encoding a urate transporter with CDK Progression. Clin. J of the Am Soc of Nephrol. 3: 1059–1065.

Преображенский Д.В., Маревич А.В., Романова Е.И. и др. Микроальбуминурия: диагностическое, клиническое и прогностическое значение (часть вторая) // РКЖ. –2000. – No 4. – С. 78–85.

Преображенский Д.В., Маренич А.В., Романова Н.Е., Киктев В.Г., Сидоренко Б.А. Микроальбуминурия: диагностическое, клиническое и прогностическое значение (часть первая) //РКЖ. – 2000, No 3. – С. 12–14.

Mogenstein C.E., Keane W.F., Bennett P.H. et al. 1995. Prevention of diabetic renal disease with special reference to microalbuminuria – Lancet, 346 (8982): 1080–1084.

Parving H.H. 1996. Microalbuminuria in essential hypertension – J. Hypertension. 14: 89–94.

Bianchi S., Bigazzi R., Baldari G, Cam pese V.M. 1991. Microalbuminuria in patients with essential hypertension. Amer. J. Hypertens. 4: 291–296.

Fauvel J.P., Haji Aissa A., Laville M. et al. 1991. // Microalbuminuria in normotensive with genetic risk of hypertension. Nephron. 57:375–376.

Grunfeid В., Perelstein E., Simolo B. et al. 1990. Renal function reserve and microalbuminuria in off springs of hypertensive patients. – Hypertension. 15:257–261.

Jalal D. 2010. Serum uric acid level predict the development of albuminuria over 6 years in patient with type 1 diabetes: findings from the coronary artery calcification in type 1 diabetes study. Nephrol. Dial. Transplant. 25: 1865–1869.

Burtis C. et al (ed.) 2006. Textbook of clinical chemistry and molecular diagnostics Saunders. 555 p.

Oetting W.S., Rogers T.B., Krick T.P. et al. 2006. Urinary beta 2 microglobulin is associated with acute renal allograft rejection. // Am J Kidney Dis. 47(5):898–904.